Education

PhD, University of Georgia, 2011

MS, University of Belgrade (Serbia), 2001

DVM equivalent, University of Belgrade (Serbia), 1996

Certifications

Diplomate, American College of Veterinary Pathologists

Research Interest

Immunomodulatory roles of Myeloid Derived Suppressor Cells in infectious diseases, tumors, and immune mediated conditions. Discovery and repurposing of FDA approved drugs for COVID-19 patients treatments. 

Publications

Chelladurai JJ, Pramasivan V, jelesijevic T, Brewer M. P-Glycoproteins are potential drugabble targets in Toxocara canis, American Association of Veterinary Parasitologists 65th annual meeting June 2020.

Jelesijevic T, Nesic V, Aleksic-Kovacevic S, Marinkovic D, Gledic D, Knezevic M, Jovanovic M. Follicle stimulating hormone receptor expression in histologically normal and neoplastic canine mammary gland tissues. Experimental Biology, April 2020.

Rajan H, Dyer R, Huang Y, Pan R, Galetta S, Zhang J, Jelesijevic T, 2020. Boa SARS- CoV-19 Open Research Dataset, http://boa.cs.iastate.edu/boac/, April 2020.

Lafontaine ER, Chen Z, Huertas MC, Dyke JS, Jelesijevic T, Michel F, Hogan RJ, He B. The autotransporter protein BatA is a protecitve antigen against lethal aerosol infection with Burkholderia mallei and Burkholderia Pseudomallei, Vaccine: X,https://doi.org/10.1016/j.jvacx.2018.100002, 2019.  

Uhl EW, Osborn ML, Michel F, Jelesijevic T, Hogan RJ. Synonymous changes in specific leucine codons impact morbilliviral protein production from human & canine codon optiomized constructs. Experimental Biology, Orlando, Florida, April 2019.

Zimmerman SM, Long M, Dyke JS, Jelesijevic T, Michel F, Lafontaine ER, and Hogan RJ. Use of immunohistochemistry to demonstrate in vivo expression of the Burkholderia mallei virulence factor BpaB during experimental glanders,Veterinary Pathology, 55(2), 258-267, 2018.  

Uhl EW, Osborn ML, Michel F, Jelesijevic T, Hogan RJ. Localized optimization of measles virus (MV) hemagglutinin (H) gene to human codon usage bias increases protein expression. Experimental Biology, San Diego, CA, April 2018

Zimmerman SM, Dyke JS, Jelesijevic T, Michel F, Lafontaine ER, and Hogan RJ. Antibodies against in vivo-expressed antigens are sufficient to protect against lethal aerosol infection with Burkholderia malleiandBurkholderia pseudomallei, Infection and Immunity, 85(8), 25 e00102-17, 2017.

Jelesijevic T, Zimmerman SM, Dyke JS, Michel F, Lafontaine ER, and Hogan RJ. Challenges in developing a glanders vaccine and possible role of myeloid-derived suppressor cells in a murine model of chronic infection, ACVP, New Orleans, Louisiana, December 2016 

Jelesijevic T, Zimmerman SM, Harvey SB, Mead DG, Shaffer TL, Estes M, Michel F, Quinn FD, Hogan RJ, Lafontaine ER. Use of the common marmoset to study Burkholderia mallei infection, Plos One, 10(4):e0124181. doi:10.1371/journal.pone.0124181, eCollection, 2015 

Grants

Expanding biosafety level 3 lab capabilities, LSU ($222 432) Skymount, 2021.

DeepDrug: AI-based Drug Discovery for SARS CoV2, LSU subaward ($83 307) Skymount, 2020.

Evaluation of Prefense hand and multi-surface pro sanitizers efficacy in SARS CoV2 inactivation, Prefense LLC ($36 661).